Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression

Autor Wang, Lei, Devarajan, Eswaran, He, Jin, Reddy, Sekhar P., Le Dai, Jia
Vydáno 2005

Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

Autor Egas-Bejar, Daniela, Anderson, Pete M., Agarwal, Rishi, Corrales-Medina, Fernando, Devarajan, Eswaran, Huh, Winston W., Brown, Robert E, Subbiah, Vivek
Vydáno 2014

Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors

Autor Jotzu, Constantin, Alt, Eckhard, Welte, Gabriel, Li, Jie, Hennessy, Bryan T., Devarajan, Eswaran, Krishnappa, Srinivasalu, Pinilla, Severin, Droll, Lilly, Song, Yao-Hua
Vydáno v Anal Cell Pathol (Amst) (2010)

BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation

Autor Lewis, Valerae O., Devarajan, Eswaran, Cardó-Vila, Marina, Thomas, Dafydd G., Kleinerman, Eugenie S., Marchiò, Serena, Sidman, Richard L., Pasqualini, Renata, Arap, Wadih
Vydáno v Proc Natl Acad Sci U S A (2017)

Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine

Autor Subbiah, Vivek, Wagner, Michael J., McGuire, Mary F., Sarwari, Nawid M., Devarajan, Eswaran, Lewis, Valerae O., Westin, Shanon, Kato, Shumei, Brown, Robert E., Anderson, Pete
Vydáno v Oncotarget (2015)